abstract |
Disclosed are inhibitors of Bcl-2 / Bcl-xL and compositions containing same. Methods of using Bcl-2 / Bcl-xL inhibitors in the treatment of diseases and conditions, such as cancer, where inhibition of Bcl-2 / Bcl-xL is beneficial are also disclosed. |